Patrick Reeves
3Patents
1h-index
4Co-inventors
33Inventor score
Filing activity: Dec 16, 2010 → Aug 5, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8765777B2 | Compositions and methods of use for tyrosine kinase inhibitors to treat pathogenic infection | Emerging Cross-Sectional Technologies | 2 | Active |
| US11305017B2 | Anti-fugetactic agent and anti-cancer agent combination therapy and compositions for the treatment of cancer | Chemistry; Metallurgy | 0 | Active |
| US11419894B2 | Modified natural killer cells for the treatment of cancer | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.